chr10-22209649-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001394757.1(EBLN1):āc.335A>Cā(p.Glu112Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000417 in 1,535,904 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001394757.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152226Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000308 AC: 4AN: 130026Hom.: 0 AF XY: 0.0000282 AC XY: 2AN XY: 70936
GnomAD4 exome AF: 0.0000369 AC: 51AN: 1383560Hom.: 0 Cov.: 33 AF XY: 0.0000381 AC XY: 26AN XY: 682688
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152344Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2021 | The c.335A>C (p.E112A) alteration is located in exon 1 (coding exon 1) of the EBLN1 gene. This alteration results from a A to C substitution at nucleotide position 335, causing the glutamic acid (E) at amino acid position 112 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at